Facioscapulohumeral muscular dystrophy’s game of homeodomains: therapy wants a biomarker as a sword wants a whetstone

This scientific commentary refers to ‘The FSHD muscle-blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy’, by Banerji et al. (https://doi.org/10.1093/braincomms/fcad221).

Detalles Bibliográficos
Autores principales: Kyba, Michael, Bosnakovski, Darko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Scientific Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507743/
https://www.ncbi.nlm.nih.gov/pubmed/37731901
http://dx.doi.org/10.1093/braincomms/fcad235
_version_ 1785107378903973888
author Kyba, Michael
Bosnakovski, Darko
author_facet Kyba, Michael
Bosnakovski, Darko
author_sort Kyba, Michael
collection PubMed
description This scientific commentary refers to ‘The FSHD muscle-blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy’, by Banerji et al. (https://doi.org/10.1093/braincomms/fcad221).
format Online
Article
Text
id pubmed-10507743
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105077432023-09-20 Facioscapulohumeral muscular dystrophy’s game of homeodomains: therapy wants a biomarker as a sword wants a whetstone Kyba, Michael Bosnakovski, Darko Brain Commun Scientific Commentary This scientific commentary refers to ‘The FSHD muscle-blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy’, by Banerji et al. (https://doi.org/10.1093/braincomms/fcad221). Oxford University Press 2023-09-02 /pmc/articles/PMC10507743/ /pubmed/37731901 http://dx.doi.org/10.1093/braincomms/fcad235 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Scientific Commentary
Kyba, Michael
Bosnakovski, Darko
Facioscapulohumeral muscular dystrophy’s game of homeodomains: therapy wants a biomarker as a sword wants a whetstone
title Facioscapulohumeral muscular dystrophy’s game of homeodomains: therapy wants a biomarker as a sword wants a whetstone
title_full Facioscapulohumeral muscular dystrophy’s game of homeodomains: therapy wants a biomarker as a sword wants a whetstone
title_fullStr Facioscapulohumeral muscular dystrophy’s game of homeodomains: therapy wants a biomarker as a sword wants a whetstone
title_full_unstemmed Facioscapulohumeral muscular dystrophy’s game of homeodomains: therapy wants a biomarker as a sword wants a whetstone
title_short Facioscapulohumeral muscular dystrophy’s game of homeodomains: therapy wants a biomarker as a sword wants a whetstone
title_sort facioscapulohumeral muscular dystrophy’s game of homeodomains: therapy wants a biomarker as a sword wants a whetstone
topic Scientific Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507743/
https://www.ncbi.nlm.nih.gov/pubmed/37731901
http://dx.doi.org/10.1093/braincomms/fcad235
work_keys_str_mv AT kybamichael facioscapulohumeralmusculardystrophysgameofhomeodomainstherapywantsabiomarkerasaswordwantsawhetstone
AT bosnakovskidarko facioscapulohumeralmusculardystrophysgameofhomeodomainstherapywantsabiomarkerasaswordwantsawhetstone

Ejemplares similares